Bachir Sakr

Clinical trials

• Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for Relapse

  Principal investigator · Terminated · Phase 2

  Brown University

  2007–2014
• ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

  Site PI · Recruiting · Phase 3

  Alliance for Clinical Trials in Oncology

  2025–2037
• Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

  Site PI · Recruiting · Phase 3

  NRG Oncology

  2023–2034
• Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

  Site PI · Recruiting · Phase 3

  Alliance for Clinical Trials in Oncology

  2023–2033